Stuart Peterson, founder and Managing General Partner of Artis Ventures. See sector focus and contact routes.
Stuart Peterson, founder and Managing General Partner of Artis Ventures, invests primarily in early-stage (seed to Series A) companies at the intersection of artificial intelligence, biotech, and digital health—a distinctive “TechBio” thesis where software transforms biology and medicine. His notable portfolio includes category-defining exits such as Palantir (IPO), YouTube (acquired by Google), StemCentrx (acquired by AbbVie), IDbyDNA (acquired by Illumina), and current board companies like Rad AI, Seed Health, and Affect Therapeutics. Artis’s $200M TechBio II fund (closed December 2023) is dedicated exclusively to this early-stage mandate, backing founders with breakthrough scientific or engineering insights.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in San Francisco when building a target list.
Investors like Stuart Peterson · Full investor directory · Investor access · Company funding database